Cost-effectiveness of prophylaxis with palivizumab among high-risk children in Hong Kong: abridged secondary publication

被引：0
|
作者：
Wu, P. [1 ]
Cowling, B. J. [1 ]
Chiu, S. S. [2 ]
Wong, I. O. L. [1 ]
Yeung, W. K. Y. [3 ]
机构：
[1] Univ Hong Kong, Sch Publ Hlth, LKS Fac Med, Hong Kong, Peoples R China
[2] Univ Hong Kong, LKS Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
[3] Pamela Youde Nethersole Eastern Hosp, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
来源：
HONG KONG MEDICAL JOURNAL | 2023年 / 29卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of screening and management strategies for chlamydia control in Hong Kong: abridged secondary publication
    Wong, W. C. W.
    Wong, C.
    Ong, J.
    Fairley, C.
    Hocking, J.
    HONG KONG MEDICAL JOURNAL, 2023, 29 (01) : 27 - 31
  • [2] Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: A cost-effectiveness analysis
    Lolfand, JH
    Touch, SM
    O'Connor, JP
    Chatterton, ML
    Moxey, ED
    Paddock, LE
    Nash, DB
    Desai, SA
    CLINICAL THERAPEUTICS, 2000, 22 (11) : 1357 - 1369
  • [3] SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF PALIVIZUMAB IN HIGH-RISK PATIENTS
    Paladio Duran, N.
    Garcia-Altes, A.
    Pons Rafols, J. M.
    Tebe Cordomi, C.
    VALUE IN HEALTH, 2009, 12 (07) : A432 - A432
  • [4] Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children - A UK analysis
    Nuijten, Mark J. C.
    Wittenberg, Wolfgang
    Lebmeier, Maximilian
    PHARMACOECONOMICS, 2007, 25 (01) : 55 - 71
  • [5] Maximising the cost-effectiveness of human papillomavirus testing for cervical screening in the context of routine HPV vaccination in Hong Kong: abridged secondary publication
    Leung, S. M. K.
    Wu, J.
    Chan, K. K. L.
    Jit, M.
    HONG KONG MEDICAL JOURNAL, 2023, 29 (04) : 11 - 15
  • [6] Severity profiles of respiratory viruses in children in Hong Kong: abridged secondary publication
    Wu, P.
    Cowling, B. J.
    Peiris, J. S. M.
    HONG KONG MEDICAL JOURNAL, 2020, 26 (03) : 17 - 21
  • [7] Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria
    Resch, Bernhard
    Gusenleitner, Walter
    Nuijten, Mark J. C.
    Lebmeier, Maximilian
    Wittenberg, Wolfgang
    CLINICAL THERAPEUTICS, 2008, 30 (04) : 749 - 760
  • [8] Secular trends of blood pressure in children and adolescents in Hong Kong: abridged secondary publication
    Kwok, M. K.
    Tu, Y. K.
    Wong, I. O. L.
    Lin, S. L.
    Schooling, C. M.
    HONG KONG MEDICAL JOURNAL, 2020, 26 (06) : 10 - 13
  • [9] Traffic-related air pollution and Hong Kong school children: abridged secondary publication
    Lao, X. Q.
    Lau, A. P. S.
    Wong, C. H. Y.
    Yu, T. S., I
    HONG KONG MEDICAL JOURNAL, 2020, 26 (06) : 6 - 9
  • [10] Human parechovirus infection in Hong Kong neonates, infants, and young children: abridged secondary publication
    Chan, P. K. S.
    Chan, M. C. W.
    Nelson, E. A. S.
    Leung, T. F.
    HONG KONG MEDICAL JOURNAL, 2020, 26 (03) : 8 - 11
12345